Boehringer Ingelheim is collaborating with the online patient community PatientsLikeMe on the rare lung condition idiopathic pulmonary fibrosis (IPF).
The partnership, announced to coincide with last week's Rare Diseases Day, will see Boehringer help enhance PatientsLikeMe's existing IPF community.
This will take the form of providing what PatientsLikeMe says will be a “customised experience” for its users that will allow them monitor their health and progress over time and connect with others to learn more about the condition.
PatientsLikeMe co-founder and president Ben Heywood said: “We are excited to partner with Boehringer Ingelheim, a leading pharmaceutical company, to support this patient initiative.
Via Dinesh Chindarkar